If you liked this article you might like

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers
Cramer: These Sectors Look Bullish (Part III)
Cramer: There Are Powerful Themes in Several Bull Markets
Cramer: These Stocks Look Like 'Easy Pickings'